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S236 Poster Session Idemonstrated that extrathymic T cell development occurs in BMT
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a broad TCR repertoire.223
FLT-3 LIGAND ENHANCES THYMOPOIESIS IN HEMATOPOIETIC STEM
CELL TRANSPLANTS (HSCT) INVOLVING AGED DONOR AND RECIPIENT
MICE BY INCREASING SURVIVAL AND TRAFFICKING OF EARLY THYMO-
CYTE PROGENITORS
Williams, K.M., Moore, A.R., Gress, R.E. National Institutes of Health,
Bethesda, MD
Impaired thymopoiesis may contribute to graft-versus-host dis-
ease and poor clearance of infections. Early thymic precursor fre-
quency is a point of regulation for thymus reconstitution;
however, it is unknown if decreased thymus recovery with age is
due to the absence of thymus elements or marrow precursors.
To address this, we investigated whether marrow thymus precur-
sor frequency declines with age, contributes to poor aged thymus
recovery, and can be enhanced with FMS-like tyrosine kinase 3
(Flt-3), a growth factor for HSC. Total number of HSC (LSK,
Lineage- Sca-11 and cKit1) and Flt-3R1 LSK were equivalent
in the marrow of old (. 4 months) and young mice (1 month).
By ELISA, marrow concentration of Flt-3L was equivalent be-
tween old and young mice. Similarly, there was no difference in
splenic LSK numbers. However, the response to exogenous Flt-
3L was distinct by age. While young marrow was unaffected after
Flt-3L, in aged mice, total LSK and CCR91 thymus directed
LSK increased 4 fold (p\ 0.05). The proportion of LSK that ex-
pressed Flt-3R decreased in the marrow of older mice in response
to Flt3-L and LSK proliferation (Ki67 and BrdU) did not differ in
response to Flt3-L in old or young mice, consistent with im-
proved survival rather than proliferation. We then hypothesized
that Flt-3L treated cells may also traffic to peripheral spaces, sim-
ilar to GCSF. Consistent with this theory, in the spleen of old and
young mice, the Flt3-R1 LSK number increased in response to
Flt3-L (p \ 0.05). We then used aged Flt3-L knock-out mice
(Flt3-L2/2) to test whether survival and trafficking were part
of the mechanism of Flt3-L. Aged Flt3-L 2/2 mice had signifi-
cantly lower LSK and Flt3-R1 LSK in the marrow than wild
type aged counterparts, consistent with a deficient survival signal.
After Flt3-L exposure, although Flt3-R proportion was un-
changed in the marrow, LSK numbers increased significantly in
the spleen (p\ 0.05) with equivalent Ki67, suggesting LSK traf-
ficked from marrow to spleen. Aged donor Flt3-L treated marrow
with lupron-treated aged host increased donor thymocytes two-
fold within 5 weeks after transplantation (p \ 0.05) compared
to lupron alone. Collectively, these data suggest that marrow
LSK milieu contributes to thymus dysfunction in older donor/
host recipient pairs and that Flt-3L may improve thymus recovery
by enhancing survival and trafficking of older donor HSC.224
CD31CD41 AND CD31CD81-LYMPHOCYTES AS BIOMARKERS PRE-
DICTING THE LONG TERM OUTCOME OF PEDIATRIC HAEMATOPOIETIC
STEM CELL TRANSPLANTATION RECIPIENTS
Bartelink, I.H.1, Belitser, S.V.2, Knibbe, C.A.J.3,4, Danhof, M.4, de
Pagter, A.J.1, Egberts, A.C.G.1,2, Boelens, J.J.1 1UniversityMedical Cen-
ter Utrecht, Utrecht, Netherlands; 2Utrecht University, Utrecht, Nether-
lands; 3St. Antonius Hospital, Nieuwegein, Netherlands; 45 Leiden/
Amsterdam Center for Drug Research, Division of Pharmacology, Leiden
University, Leiden, Netherlands
Introduction: Haematopoietic stem cell transplantation (HSCT)
may be complicated by severe infectious complications, graft-ver-
sus-host disease (GvHD) and relapse/graft failures the probability
thereof depends on the lymphocyte immune reconstitution. The
goal of this study was to identify biomarkers of immune reconstitu-
tion in the first period after transplantation that may predict
outcome.Methods: Children transplanted between 2005-2007 in the
UMCU were prospectively included. Immunophenotyping was
performed every two weeks after HSCT. Several parameters of
immune reconstitution in relation with survival, acute- and
chronic-GvHD were studied, using a multiplicative intensity
model in R: AUC, the time and maximum CD31CD41,
CD31CD81 T-cell and CD191B-cell numbers, the ratio be-
tween CD4/CD8 and the relationship between naive and memory
cells in the period 0-90,0-180 and 180-360 days. Data were strat-
ified to donor source. Relations were tested in linear, logaritmic
and parabolar functions. The differences between models were
compared using the P-values and diagnostics of the model. Based
on the resulting model, we defined a cut off value to describe op-
timal survival per biomarker.
Results: 56 recipients received bone marrow, 12 received a sibling
donor, while 26 patients received cord blood derived stem cells.
The median age at HSCT was 5.9 years (range 0.11 – 18.1).
The max nr of CD41 cells related to their age related reference
values in the first 6 months after HSCT positively predicted sur-
vival (HR 0.43, CI95% 0.29-0.63), with a cutoff point of 0.15. In
Cord blood transplants the CD4/8 ratio within the first half year
. 5 was a predictor for survival (HR 5 0.6 CI95% 0.40-0.91).
In BM/sibling transplants, the maximum number of CD8 cells
related to their age related reference values . 1 positively pre-
dicted survival within the first half year (HR 5 0.68, CI95%
0.46-1.01).
Conclusion: CD31CD41 and CD31CD81 divided by their age
related reference values, predicted outcome early after HSCT in
children and may be used in future studies and in clinical practice,
after further validation of these relationships.225
IMMUNE RECONSTITUTION IN HEMATOPOIETIC CELL TRANSPLANTA-
TION PATIENTS RECEIVING ATG AS PART OF CONDITIONING REGIME
Hoegh-Petersen, M., Dhadda, M., Liu, Y., Hagel, L., Podgorny, P.J.,
Ugarte-Torres, A., Storek, J. University of Calgary, Calgary, AB, Canada
Introduction: Successful immunological recovery in recipients of
hematopoietic cell transplantation (HCT) is important for trans-
plant success. Use of anti-thymocyte globulin (ATG) as part of
the pre-transplant conditioning has shown to decrease graft versus
host disease (GvHD). However the impact of ATG on immuno-
logical recovery has not been studied. Here we studied the factors
influencing immune cell recovery after ATG-conditioned HCT.
Patients and Methods: Immune subsets were quantified in 176 al-
logeneic HCT recipients receiving ATG during conditioning, at day
28, 56, 84, 180, 365 and 730 post transplantation. Following lym-
phocyte subsets were quantified: B cells, CD4 T cells and CD8 T
cells (incl. their naive and memory/effector [mem/eff] subsets), NK
cells (incl. regulatory and cytolytic subsets), monocytes and dendritic
cells (DC) (incl. plasmacytoid and myeloid subsets). Day 7 serum
levels of ATGwere quantified by flow cytometry. Significance of as-
sociations between immune cell subset counts and factors suspected
to influence themwere tested usingMann-Whitney rank sum test for
categorical factors and Spearman rank correlation test for continu-
ous variable/factors.
Results: Higher recipient age was associated with lower na€ıve
CD4 and CD8 T cell counts on days 180, 365 and 730. Graft con-
tent of specific subsets positively correlated with counts of the
same subset early posttransplant in the case of B cells (both naive
and memory), CD4 and CD8 T cells (both naive and mem/eff),
and myeloid DCs. Significant GvHD (grade 2-4 acute or moder-
ate-severe chronic) was associated with significantly lower B cell
counts (including naive and memory) on days 56-180, regulatory
NK cells on days 28-56, plasmacytoid DCs on day 28-84 and
higher counts of naive CD8 T cells on days 28-84. High day 7 se-
rum ATG levels were associated with decreased CD4 and CD8 T
cell counts and increased regulatory NK cell counts early, but for
most subsets not late posttransplant. Graft CD34 cell count and
recipient CMV serostatus showed no positive correlation with
any immune cell subset count.
